The Open Loop with Chay Carter
Personalised Neuromodulation for Alzheimer’s with Ken Mariash
· 37 Min.
Shownotes
In this episode of The Open Loop, Chay Carter is joined by Ken Mariash, CEO of Sinaptica Therapeutics.
Ken shares how Sinaptica is developing a non-invasive, personalised neuromodulation therapy designed to slow the progression of Alzheimer’s disease by targeting the brain networks involved in memory.
This is a practical conversation about moving beyond amyloid-only thinking and looking at Alzheimer’s as a disease of network dysfunction.
We also explore Ken’s background in medtech, biopharma, and neuromodulation, as well as Sinaptica’s Phase 2 data, pivotal trial plans, reimbursement…
